Abstract OT3-03-04: NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) &/or surgical ablation for newly oligometastatic breast cancer

Chmura, SJ ; Winter, KA ; Salama, JK ; Woodward, WA ; Borges, VF ; Al-Hallaq, H ; Matuszak, M ; Jaskowiak, NT ; Milano, MT ; Bandos, H ; White, JR

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.OT3-03-04-OT3-03-04 [Periódico revisado por pares]

Texto completo disponível